Effects of Vitamin D Supplementation in Atorvastatin‐Treated Patients: A New Drug Interaction With an Unexpected Consequence

@article{Schwartz2009EffectsOV,
  title={Effects of Vitamin D Supplementation in Atorvastatin‐Treated Patients: A New Drug Interaction With an Unexpected Consequence},
  author={J. Schwartz},
  journal={Clinical Pharmacology & Therapeutics},
  year={2009},
  volume={85}
}
  • J. Schwartz
  • Published 2009
  • Chemistry, Medicine
  • Clinical Pharmacology & Therapeutics
  • The objective of this study was to determine vitamin D supplementation effects on concentrations of atorvastatin and cholesterol in patients. Sixteen patients (8 men, 8 women; 10 Caucasians, 4 African Americans, 1 Hispanic, 1 Asian), aged 63 ± 11 years (mean ± SD, weight 92 ± 31 kg) on atorvastatin (45 ± 33 mg/day) were studied with and without supplemental vitamin D (800 IU/day for 6 weeks). Levels of vitamin D (1,25‐dihydroxy(OH) and 25 OH‐metabolites), atorvastatin (parent, OH‐acid… CONTINUE READING
    82 Citations

    Topics from this paper.

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The investigators planned to research the effect of vitamin D supplementation as an adjuvant therapy for patients with hypercholesterolemia.  
    ConditionsPrimary Hypercholesterolemia
    InterventionDrug
    Effect of vitamin D on bioavailability and lipid lowering efficacy of simvastatin
    • 5
    • Highly Influenced
    Vitamin D Levels and Lipid Response to Atorvastatin
    • 29
    • PDF
    Serum Levels of 25-Hydroxyvitamin D and the CYP3A Biomarker 4β-Hydroxycholesterol in a High-Dose Vitamin D Supplementation Study
    • 15
    • PDF
    Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials
    • 172

    References

    SHOWING 1-10 OF 37 REFERENCES
    Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease.
    • 164
    • PDF
    Vitamin D Deficiency and Risk of Cardiovascular Disease
    • 2,191
    • PDF
    Clinical Pharmacokinetics of Atorvastatin
    • 437
    Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements.
    • 126